| 1 |
33275817 | Targeted inhibition of ERα signaling and PIP5K1α/Akt pathways in castration-resistant prostate cancer. | 2021 Apr |
1 |
| 2 |
33519190 | Paeoniflorin Sensitizes Breast Cancer Cells to Tamoxifen by Downregulating microRNA-15b via the FOXO1/CCND1/β-Catenin Axis. | 2021 |
1 |
| 3 |
33708885 | FEN1 is a prognostic biomarker for ER+ breast cancer and associated with tamoxifen resistance through the ERα/cyclin D1/Rb axis. | 2021 Feb |
4 |
| 4 |
33839437 | The prognostic value of cyclin D1 in breast cancer patients treated with hormonal therapy: A pilot study. | 2021 Jun |
1 |
| 5 |
31975484 | Overcoming tamoxifen resistance in oestrogen receptor-positive breast cancer using the novel thiosemicarbazone anti-cancer agent, DpC. | 2020 May |
1 |
| 6 |
32722075 | Tamoxifen and the PI3K Inhibitor: LY294002 Synergistically Induce Apoptosis and Cell Cycle Arrest in Breast Cancer MCF-7 Cells. | 2020 Jul 24 |
1 |
| 7 |
33050377 | Significance of Targeting VEGFR-2 and Cyclin D1 in Luminal-A Breast Cancer. | 2020 Oct 10 |
1 |
| 8 |
33139730 | LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer. | 2020 Nov 2 |
5 |
| 9 |
33177647 | Coffee decoction enhances tamoxifen proapoptotic activity on MCF-7 cells. | 2020 Nov 11 |
1 |
| 10 |
30467747 | The modulatory role of low concentrations of bisphenol A on tamoxifen-induced proliferation and apoptosis in breast cancer cells. | 2019 Jan |
1 |
| 11 |
31742207 | Inhibition of tamoxifen's therapeutic effects by emodin in estrogen receptor-positive breast cancer cell lines. | 2019 Nov |
1 |
| 12 |
28415819 | Aspirin regulation of c-myc and cyclinD1 proteins to overcome tamoxifen resistance in estrogen receptor-positive breast cancer cells. | 2017 May 2 |
6 |
| 13 |
27519631 | Tamoxifen has a proliferative effect in endometrial carcinoma mediated via the GPER/EGFR/ERK/cyclin D1 pathway: A retrospective study and an in vitro study. | 2016 Dec 5 |
1 |
| 14 |
25846733 | ObRb downregulation increases breast cancer cell sensitivity to tamoxifen. | 2015 Sep |
1 |
| 15 |
23755153 | The effect of antineoplastic drugs in a male spontaneous mammary tumor model. | 2014 |
1 |
| 16 |
24563328 | Expression profiling of breast cancer patients treated with tamoxifen: prognostic or predictive significance. | 2014 Apr |
1 |
| 17 |
23874806 | Changes in the transcriptome of the human endometrial Ishikawa cancer cell line induced by estrogen, progesterone, tamoxifen, and mifepristone (RU486) as detected by RNA-sequencing. | 2013 |
2 |
| 18 |
24367492 | RSF1 and not cyclin D1 gene amplification may predict lack of benefit from adjuvant tamoxifen in high-risk pre-menopausal women in the MA.12 randomized clinical trial. | 2013 |
2 |
| 19 |
22266527 | Low-dose dietary genistein negates the therapeutic effect of tamoxifen in athymic nude mice. | 2012 Apr |
1 |
| 20 |
22422660 | Furanodiene enhances tamoxifen-induced growth inhibitory activity of ERa-positive breast cancer cells in a PPARγ independent manner. | 2012 Aug |
2 |
| 21 |
22475046 | Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study. | 2012 Apr 4 |
4 |
| 22 |
19636701 | Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancers. | 2010 Jun |
3 |
| 23 |
20010939 | Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells. | 2010 Jan 19 |
1 |
| 24 |
19584281 | Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway. | 2009 Jul 15 |
1 |
| 25 |
18245487 | Tamoxifen stimulates the growth of cyclin D1-overexpressing breast cancer cells by promoting the activation of signal transducer and activator of transcription 3. | 2008 Feb 1 |
8 |
| 26 |
18280643 | Free circulating mRNA in plasma from breast cancer patients and clinical outcome. | 2008 May 18 |
1 |
| 27 |
18347178 | Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy. | 2008 Mar 15 |
3 |
| 28 |
18393977 | Genetic alterations of CCND1 and EMSY in breast cancers. | 2008 May |
1 |
| 29 |
18823530 | Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer. | 2008 |
2 |
| 30 |
19202962 | [Factors predicting failure of adjuvant hormonotherapy of breast carcinoma. A study in tamoxifen treated patients]. | 2008 |
1 |
| 31 |
17486065 | Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer. | 2007 Oct 25 |
2 |
| 32 |
17593037 | Cyclin D-1, interleukin-6, HER-2/neu, transforming growth factor receptor-II and prediction of relapse in women with early stage, hormone receptor-positive breast cancer treated with tamoxifen. | 2007 Jul-Aug |
1 |
| 33 |
17640162 | Dietary flaxseed interaction with tamoxifen induced tumor regression in athymic mice with MCF-7 xenografts by downregulating the expression of estrogen related gene products and signal transduction pathways. | 2007 |
2 |
| 34 |
16705121 | Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients. | 2006 May 17 |
1 |
| 35 |
16740736 | Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: a mechanism of tamoxifen resistance. | 2006 Jun 1 |
1 |
| 36 |
17145896 | Cyclin D1 is necessary for tamoxifen-induced cell cycle progression in human breast cancer cells. | 2006 Dec 1 |
7 |
| 37 |
15868442 | Role of cyclin D1 in ErbB2-positive breast cancer and tamoxifen resistance. | 2005 May |
3 |
| 38 |
16140974 | Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with cyclin D1 gene amplification. | 2005 Sep 1 |
4 |
| 39 |
15138474 | A prognostic index for operable, node-negative breast cancer. | 2004 May 17 |
1 |
| 40 |
15138475 | Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients. | 2004 May 17 |
3 |
| 41 |
15544931 | Cyclin D1 expression is dependent on estrogen receptor function in tamoxifen-resistant breast cancer cells. | 2004 Sep |
7 |
| 42 |
15585645 | Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines. | 2004 Dec 1 |
2 |
| 43 |
12469160 | Cyclin D1 expression and patient outcome after tamoxifen therapy in estrogen receptor positive metastatic breast cancer. | 2003 Jan-Feb |
3 |
| 44 |
12612058 | Tamoxifen functions as a molecular agonist inducing cell cycle-associated genes in breast cancer cells. | 2003 Feb |
2 |
| 45 |
10661763 | Characterization of a human melanoma cell line with non-oestrogen receptor dependent tamoxifen resistance. | 1999 Dec |
1 |
| 46 |
9199341 | Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution. | 1997 Jul |
1 |
| 47 |
9815758 | Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth-inhibitory effects of antiestrogens. | 1997 Jun |
1 |
| 48 |
7585469 | Growth arrest associated changes of mRNA levels in breast cancer cells measured by semi-quantitative RT-PCR: potential early indicators of treatment response. | 1995 Oct 20 |
1 |